Duran; Adil

Patent Applications and Registrations

Patent applications and USPTO patent grants for Duran; Adil.The latest application filed is for "process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines".

Company Profile

0.21.30

Duran; Adil - Biberach an der Riss DE
Duran; Adil - Rissegg N/A DE
Duran; Adil - Rigefield CT US
Duran; Adil - Biberach DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines Grant 9,751,855 - Pfrengle , et al. September 5, 2	2017-09-05
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines App 20170129872 - PFRENGLE; Waldemar ; et al.	2017-05-11
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines App 20170029402 - PFRENGLE; Waldemar ; et al.	2017-02-02
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines Grant 9,499,546 - Pfrengle , et al. November 22, 2	2016-11-22
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines App 20150025089 - PFRENGLE; Waldemar ; et al.	2015-01-22
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines Grant 8,883,805 - Pfrengle , et al. November 11, 2	2014-11-11
Process for the manufacturing of CRR inhibitors Grant 8,680,280 - Duran , et al. March 25, 2	2014-03-25
Process For The Manufacturing Of Crr Inhibitors App 20130261307 - DURAN; Adil ; et al.	2013-10-03
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines App 20130178485 - PFRENGLE; Waldemar ; et al.	2013-07-11
Process for the manufacturing of betamimetics Grant 8,420,809 - Krueger , et al. April 16, 2	2013-04-16
Regioselective Preparation Of Substituted Pyrimidines App 20130079518 - LINZ; Guenter ; et al.	2013-03-28
Regioselective Preparation Of Substituted Pyrimidines App 20130079519 - DURAN; Adil ; et al.	2013-03-28
Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug Grant 8,394,791 - Werthmann , et al. March 12, 2	2013-03-12
Regioselective preparation of substituted pyrimidines Grant 8,372,974 - Linz , et al. February 12, 2	2013-02-12
Regioselective preparation of substituted pyrimidines Grant 8,334,383 - Duran , et al. December 18, 2	2012-12-18
Process for making certain compounds having B1 antagonistic activity Grant 8,207,335 - Duran , et al. June 26, 2	2012-06-26
Process for the manufacture of fused piperazin-2-one derivatives Grant RE43,115 - Duran , et al. January 17, 2	2012-01-17
Crystalline, Enantiomerically Pure Salt Form Of A Beta-agonist, And The Use Thereof As A Drug App 20110262369 - Werthmann; Ulrike ; et al.	2011-10-27
Process For The Manufacturing Of Betamimetics App 20110124859 - KRUEGER; Thomas ; et al.	2011-05-26
Regioselective Preparation Of Substituted Pyrimidines App 20110077403 - Duran; Adil ; et al.	2011-03-31
Regioselective Preparation Of Substituted Pyrimidines App 20110060141 - Linz; Guenter ; et al.	2011-03-10
Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyr- azol-3'-O-.beta.-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments Grant 7,838,500 - Kraemer , et al. November 23, 2	2010-11-23
Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines Grant 7,820,815 - Pfrengle , et al. October 26, 2	2010-10-26
Process For Preparing App 20100210842 - DURAN; Adil ; et al.	2010-08-19
Intermediate compounds for the manufacture of fused piperazin-2-one derivatives Grant 7,626,019 - Duran , et al. December 1, 2	2009-12-01
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1yl)-xanthines App 20090192314 - PFRENGLE; Waldemar ; et al.	2009-07-30
Crystalline Form Of 1' -(1-methylethyl)-4' -[(2-fluoro-4-methoxyphenyl)methyl]-5' -methyl-1h-pyrazol-3' -o-beta-d-glucopyranoside, A Method For Its Preparation And The Use Thereof For Preparing Medicaments App 20090181905 - KRAEMER; Gerd ; et al.	2009-07-16
Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyr- azol-3'-O-.beta.-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments Grant 7,524,822 - Kraemer , et al. April 28, 2	2009-04-28
Crystalline form of 1'-(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyr- azol-3'-O-beta-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments App 20070244176 - Kraemer; Gerd ; et al.	2007-10-18
Process for the Manufacture of fused piperazin-2-one derivatives App 20070219369 - Duran; Adil ; et al.	2007-09-20
Process for the Manufacture of Fused piperazin-2-one derivatives App 20070213528 - DURAN; Adil ; et al.	2007-09-13
Process for the Manufacture of fused piperazin-2-one derivatives App 20070213529 - DURAN; Adil ; et al.	2007-09-13
Process for the Manufacture of fused piperazin-2-one derivatives App 20070213531 - DURAN; Adil ; et al.	2007-09-13
Process for the Manufacture of fused piperazin-2-one derivatives App 20070213534 - DURAN; Adil ; et al.	2007-09-13
Intermediate Compounds for the Manufacture of fused piperazin-2-one derivatives App 20070213530 - Duran; Adil ; et al.	2007-09-13
Intermediate compounds for the manufacture of fused piperazin-2-one derivatives App 20070208027 - DURAN; Adil ; et al.	2007-09-06
Process for the manufacture of fused piperazin-2-one derivatives Grant 7,238,807 - Duran , et al. July 3, 2	2007-07-03
Process For The Manufacturing Of Betamimetics App 20070088160 - KRUEGER; Thomas ; et al.	2007-04-19
Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines App 20060142310 - Pfrengle; Waldemar ; et al.	2006-06-29
Process for the manufacture of fused piperazin-2-one derivatives App 20060122393 - Duran; Adil ; et al.	2006-06-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.